+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy



Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy



Pediatric Infectious Disease Journal 32(1): 39-44



Highly active antiretroviral therapy (HAART) has been associated with lipodystrophy (LD) in adults but data are more limited for children. The purpose of this study was to determine the prevalence of and risk factors for LD in Tanzanian children receiving HAART by clinical assessment and to compare the results with anthropometric data. A cross-sectional study was performed in a cohort of HIV-infected children aged 1-18 years receiving HAART in a single center in Moshi, Tanzania. Age, gender, past and current medication regimens and anthropometric measurements were recorded. A clinical scoring method was used to assess LD. Backward binary multivariate logistic regression was used to determine relationships between anthropometric measurements and the presence of clinical LD. Among 210 HIV-infected children, the prevalence of LD was 30% (95% confidence interval [CI]: 23.8-36.2) overall, 19% (95% CI: 13.7-24.3) for lipoatrophy only, 3.8% (95% CI: 1.2-6.4) for lipohypertrophy only and 7.1% (95% CI: 3.6-10.6) for the mixed type. Most cases were mild. Older age and use of stavudine increased the risk of LD. Overall, the study population was stunted but not underweight. In children with relatively lower weight-for-height (<1), only the mid-upper arm circumference was found to be associated with lipoatrophy, while nearly all anthropometric measurements were associated with lipoatrophy in the well-nourished (weight-for-height ≥1) children. Our findings demonstrate that LD is a significant problem among Tanzanian HIV-infected children receiving HAART. Anthropometric measurements predicted LD in well-nourished children but generally failed to do so in relatively wasted children. Our findings support current efforts to avoid stavudine use in children.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055159337

Download citation: RISBibTeXText

PMID: 23038217

DOI: 10.1097/INF.0b013e3182755a34


Related references

Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients. Ethiopian Medical Journal 50(3): 221-230, 2013

Body fat changes and lipodystrophy in HIV-infected children: impact of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 43(1): 121-123, 2006

Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 46(4): 451-455, 2007

Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India. African Health Sciences 14(2): 408-413, 2015

Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART). Journal of the Medical Association of Thailand 88(7): 956-966, 2005

Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy. HIV Medicine 12(1): 54-60, 2011

Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study. Journal of the International Aids Society 15(2): 17427, 2012

Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy. Jornal de Pediatria 86(1): 27-32, 2010

Efficacy of highly active antiretroviral therapy in HIV-infected, institutionalized orphaned children in Tanzania. Acta Paediatrica 96(7): 1090-1094, 2007

Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. Journal of Acquired Immune Deficiency Syndromes 32(5): 482-489, 2003

Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. Aids 15(18): 2415-2422, 2001

Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. Journal of Infectious Diseases 185(3): 299-305, 2002

Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy. HIV Medicine 7(7): 467-470, 2006

Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART). Recenti Progressi in Medicina 95(5): 265-275, 2004

Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 24(16): 3095-3099, 2006